Search research articles
Contact Us
Filters
Showing results (81-90 of 89) with videos related to
Page
of 9
Sort By:
You have reached the last page of results.
This site can display upto 89 results.
American Journal of Clinical Dermatology
|
October 21, 2021
Efficacy and Safety of a Fixed-Dose Clindamycin Phosphate 1.2%, Benzoyl Peroxide 3.1%, and Adapalene 0.15% Gel for Moderate-to-Severe Acne: A Randomized Phase II Study of the First Triple-Combination Drug
Linda Stein Gold, Hilary Baldwin, Leon H Kircik, et al.
The Journal of Dermatological Treatment
|
August 9, 2021
Efficacy and safety of proactive treatment with twice-weekly topical Cal/BD foam in patients with plaque psoriasis undergoing HPA-axis testing: a PSO-LONG subgroup analysis
Kim Papp, Zygmunt Adamski, Lyn Guenther, et al.
Pediatric Dermatology
|
March 23, 2023
Triple-combination clindamycin phosphate 1.2%/benzoyl peroxide 3.1%/adapalene 0.15% gel for moderate-to-severe acne in children and adolescents: Randomized phase 2 study
Lawrence F Eichenfield, Linda Stein Gold, Leon H Kircik, et al.
Journal of the American Association of Nurse Practitioners
|
September 14, 2018
Efficacy and safety of dupilumab for the treatment of moderate-to-severe atopic dermatitis in adults: A pooled analysis of two phase 2 clinical trials
Susan J Tofte, Kim Papp, Neil Sadick, et al.
Plastic and Reconstructive Surgery
|
October 7, 2015
Lower Face: Clinical Anatomy and Regional Approaches with Injectable Fillers
André Braz, Shannon Humphrey, Susan Weinkle, et al.
Lasers in Surgery and Medicine
|
January 31, 2006
Complications of laser dermatologic surgery
Andrea Willey, R Rox Anderson, Jose L Azpiazu, et al.
Dermatology and Therapy
|
May 9, 2024
Triple Combination Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% for Acne: Efficacy and Safety from a Pooled Phase 3 Analysis
Leon H Kircik, Linda Stein Gold, Michael Gold, et al.
Journal of Drugs in Dermatology : JDD
|
September 21, 2018
Once-Daily Oral Sarecycline 1.5 mg/kg/day Is Effective for Moderate to Severe Acne Vulgaris: Results from Two Identically Designed, Phase 3, Randomized, Double-Blind Clinical Trials
Angela Moore, Lawrence J Green, Suzanne Bruce, et al.
JAMA Dermatology
|
June 17, 2026
Development of a Core Outcome Domain Set for Facial Aging
McKenzie A Dirr, Areeba Ahmed, Daniel I Schlessinger, et al.
Page
of 9
Search research articles
Search
Showing results (81-90 of 89) with videos related to
Sort By:
Page
of 9
You have reached the last page of results.
This site can display upto 89 results.
American Journal of Clinical Dermatology
|
October 21, 2021
Efficacy and Safety of a Fixed-Dose Clindamycin Phosphate 1.2%, Benzoyl Peroxide 3.1%, and Adapalene 0.15% Gel for Moderate-to-Severe Acne: A Randomized Phase II Study of the First Triple-Combination Drug
Linda Stein Gold, Hilary Baldwin, Leon H Kircik, et al.
The Journal of Dermatological Treatment
|
August 9, 2021
Efficacy and safety of proactive treatment with twice-weekly topical Cal/BD foam in patients with plaque psoriasis undergoing HPA-axis testing: a PSO-LONG subgroup analysis
Kim Papp, Zygmunt Adamski, Lyn Guenther, et al.
Pediatric Dermatology
|
March 23, 2023
Triple-combination clindamycin phosphate 1.2%/benzoyl peroxide 3.1%/adapalene 0.15% gel for moderate-to-severe acne in children and adolescents: Randomized phase 2 study
Lawrence F Eichenfield, Linda Stein Gold, Leon H Kircik, et al.
Journal of the American Association of Nurse Practitioners
|
September 14, 2018
Efficacy and safety of dupilumab for the treatment of moderate-to-severe atopic dermatitis in adults: A pooled analysis of two phase 2 clinical trials
Susan J Tofte, Kim Papp, Neil Sadick, et al.
Plastic and Reconstructive Surgery
|
October 7, 2015
Lower Face: Clinical Anatomy and Regional Approaches with Injectable Fillers
André Braz, Shannon Humphrey, Susan Weinkle, et al.
Lasers in Surgery and Medicine
|
January 31, 2006
Complications of laser dermatologic surgery
Andrea Willey, R Rox Anderson, Jose L Azpiazu, et al.
Dermatology and Therapy
|
May 9, 2024
Triple Combination Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% for Acne: Efficacy and Safety from a Pooled Phase 3 Analysis
Leon H Kircik, Linda Stein Gold, Michael Gold, et al.
Journal of Drugs in Dermatology : JDD
|
September 21, 2018
Once-Daily Oral Sarecycline 1.5 mg/kg/day Is Effective for Moderate to Severe Acne Vulgaris: Results from Two Identically Designed, Phase 3, Randomized, Double-Blind Clinical Trials
Angela Moore, Lawrence J Green, Suzanne Bruce, et al.
JAMA Dermatology
|
June 17, 2026
Development of a Core Outcome Domain Set for Facial Aging
McKenzie A Dirr, Areeba Ahmed, Daniel I Schlessinger, et al.
Page
of 9